title: Recent clinical advances in lung cancer management.
abstract: Progress in lung cancer therapy has been slow but steady and has accelerated due to improvements in scientific basis for the disease and to technologic advances in diagnosis and therapy. The elusive goal of reduced mortality rates can be achieved in the next 50 years through continued interdisciplinary research efforts.
authors.affiliation: University of Texas Southwestern Medical Center, Dallas, TX.
authors.forename: David H
authors.initials: DH
authors.lastname: Johnson
authors.forename: Joan H
authors.initials: JH
authors.lastname: Schiller
authors.forename: Paul A
authors.initials: PA
authors.lastname: Bunn
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D003131:Combined Modality Therapy; D055088:Early Detection of Cancer; D066246:ErbB Receptors / Q000235:genetics; D018773:Genes, erbB-1; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D009367:Neoplasm Staging; D055752:Small Cell Lung Carcinoma / Q000473:pathology* / Q000628:therapy*
chemical_list: D066246:ErbB Receptors